Vertex’s Type 1 Diabetes Cell Therapy Gets A Boost – And Some Competition

Sernova One Step Ahead On Implantable Device

 
• By Andrew McConaghie
Vertex HQ, Boston

More from Alimentary/Metabolic

More from Therapeutic Category